Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$77.8M |
| 2 |
Teradyne
TER
|
+$56.5M |
| 3 |
UiPath
PATH
|
+$54.3M |
| 4 |
Meta Platforms (Facebook)
META
|
+$49.3M |
| 5 |
Twilio
TWLO
|
+$46.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$330M |
| 2 |
Shopify
SHOP
|
+$289M |
| 3 |
DraftKings
DKNG
|
+$135M |
| 4 |
Tesla
TSLA
|
+$119M |
| 5 |
10x Genomics
TXG
|
+$56.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.32% |
| 2 | Healthcare | 30.54% |
| 3 | Consumer Discretionary | 12.52% |
| 4 | Communication Services | 9.34% |
| 5 | Financials | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
NVIDIA
NVDA
$5.2T
| $125M | 0.83% |
2,957,320
-1,185,870
| -29% | -$39.4M |
|
|
27
Palantir
PLTR
$432B
| $105M | 0.69% |
+6,842,989
| New | +$77.8M |
|
28
Kratos Defense & Security Solutions
KTOS
$10.7B
| $104M | 0.69% |
7,278,529
+166,018
| +2% | +$2.25M |
|
29
Trimble
TRMB
$14B
| $103M | 0.69% |
1,954,457
+52,775
| +3% | +$2.58M |
|
30
Ionis Pharmaceuticals
IONS
$9.93B
| $99.4M | 0.66% |
2,422,631
-214,561
| -8% | -$8.24M |
|
|
VERV
31
DELISTED
Verve Therapeutics
VERV
| $96.6M | 0.64% |
5,150,851
+668,760
| +15% | +$11.1M |
|
32
Iridium Communications
IRDM
$5.19B
| $96.2M | 0.64% |
1,548,046
+95,394
| +7% | +$5.9M |
|
|
ACCD
33
DELISTED
Accolade Inc
ACCD
| $76.6M | 0.51% |
5,683,906
-54,806
| -1% | -$712K |
|
34
Adaptive Biotechnologies
ADPT
$4.15B
| $70.1M | 0.46% |
10,453,752
+1,248,627
| +14% | +$9.28M |
|
35
AeroVironment
AVAV
$8.14B
| $61.4M | 0.41% |
600,314
+7,691
| +1% | +$774K |
|
|
36
Meta Platforms (Facebook)
META
$1.4T
| $57.3M | 0.38% |
+199,745
| New | +$49.3M |
|
37
CareDx
CDNA
$2.51B
| $56.4M | 0.37% |
6,638,350
-161,089
| -2% | -$1.34M |
|
38
Arcturus Therapeutics
ARCT
$382M
| $54.7M | 0.36% |
1,906,996
-78,425
| -4% | -$2.13M |
|
39
Mercado Libre
MELI
$97.5B
| $51.6M | 0.34% |
43,594
-15,857
| -27% | -$19.9M |
|
40
Cerus
CERS
$566M
| $50.8M | 0.34% |
20,657,391
-1,442,728
| -7% | -$3.43M |
|
41
Deere & Co
DE
$175B
| $47.4M | 0.31% |
117,018
-6,504
| -5% | -$2.49M |
|
42
Global E Online
GLBE
$6.81B
| $44.3M | 0.29% |
1,081,123
-96,640
| -8% | -$3.18M |
|
43
Vertex Pharmaceuticals
VRTX
$139B
| $40.7M | 0.27% |
115,671
-4,838
| -4% | -$1.63M |
|
44
Veeva Systems
VEEV
$40.3B
| $39.6M | 0.26% |
200,394
-8,219
| -4% | -$1.5M |
|
45
Archer Aviation
ACHR
$4.85B
| $37.8M | 0.25% |
9,164,717
+361,597
| +4% | +$1.02M |
|
46
3D Systems Corp
DDD
$530M
| $37.4M | 0.25% |
3,765,703
+139,036
| +4% | +$1.27M |
|
|
NVTA
47
DELISTED
Invitae Corporation
NVTA
| $36.5M | 0.24% |
32,262,934
+931,593
| +3% | +$1.17M |
|
48
Prime Medicine
PRME
$615M
| $35.9M | 0.24% |
2,449,199
+526,922
| +27% | +$7.36M |
|
|
TWOU
49
DELISTED
2U Inc
TWOU
| $35.4M | 0.23% |
292,792
-18,062
| -6% | -$2.4M |
|
50
Recursion Pharmaceuticals
RXRX
$1.88B
| $35.4M | 0.23% |
4,738,517
+1,161,655
| +32% | +$8.13M |
|
Similar funds
Cathie Wood's Q2 2023 Portfolio in Review
As of Q2 2023, Cathie Wood held 229 positions worth $15.1B, up 3.8% from $14.6B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Cathie Wood withdrew a net $772M in Q2 2023, closing 7 positions and reducing 135 holdings. Its most notable exit was Niu Technologies, an estimated $25.4K position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cathie Wood opened a new position in Palantir worth $105M.
- Cathie Wood's largest Q2 2023 buy was Palantir: 6,842,989 shares worth $105M.
- Cathie Wood added most to Teradyne in Q2 2023, an estimated $56.5M increase.
- Cathie Wood's biggest Q2 2023 reduction was Exact Sciences, cutting an estimated $330M.
- Cathie Wood fully exited Niu Technologies in Q2 2023, selling an estimated $25.4K.
- Cathie Wood's ten largest holdings make up 49% of its $15.1B portfolio in Q2 2023.
- Cathie Wood opened 8 new positions and closed 7 in Q2 2023.
- Cathie Wood's portfolio value rose 3.8% quarter-over-quarter to $15.1B.
Based on ARK Investment Management's 13F filing for Q2 2023, filed 10 Jul 2023.